I would like to outline the similarities between a polymerase chain reaction (PCR)-based site-directed mutagenesis procedure published by Xu et al. in Bi o Techniques (3) and a similar procedure published by me and co-workers a few years ago in Nucleic Acids Research (1) .
Both the procedures have common experimental steps, such as performing an inverse PCR on a PCR-generated DNA fragment in which a site-directed mutagenesis is targeted. Inverse PCR was performed using back-to-back (internal) primers, one or both of which may contain desired mutation(s). Inverse PCR products now containing the mutation(s) were then ligated and inserted into a vector, and sequencing was performed to assess the site-directed mutagenesis. Although, some minor differences exist between these two procedures. For example, Xu et al. design their initial PCR primers to their target DNA from a specific area of DNA sequence carrying the desirable restriction sites. Whereas, in our method, primers can be chosen from any area of target DNA molecule, and the desirable restriction sites were tagged to 5 ′ end of primers, for eventual cloning purposes. Xu et al. perform inverse PCR on monomeric DNA molecule, and our procedure used concatamers. Using concatamers over monomeric DNA has certain advantages, such as concatamers provide more template for PCRs, and length of original DNA fragment in which a mutations is desired can be maintained. Xu et al. have phosphorylated their back-to-back primers, whereas we have phosphorylated the whole PCR-DNA generated by first inverse PCR for the common purpose, i.e., to prevent mis-orientation during the subsequent ligation step. In addition to phosphorylating the PCR-generated DNA, we have subjected it to the endflushing with Klenow DNA polymerase to prevent addition of non-template base pairs that may occur during PCRs (2) .
In brief, considering the minor differences described above, the procedures by Xu et al. neither offer any new addition nor any significant improvement to our previously described procedure of site-directed mutagenesis by PCR (1). Further, I regret the inability of Xu et al. to quote our reference (1).
